- Home
- POLA vs NCNA Comparison
POLA vs NCNA Comparison
Compare POLA & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- NCNA
- Stock Information
- Founded
- POLA 1979
- NCNA 1997
- Country
- POLA United States
- NCNA United Kingdom
- Employees
- POLA N/A
- NCNA N/A
- Industry
- POLA Industrial Machinery/Components
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- NCNA Health Care
- Exchange
- POLA Nasdaq
- NCNA Nasdaq
- Market Cap
- POLA 5.6M
- NCNA 4.5M
- IPO Year
- POLA 2016
- NCNA 2017
- Fundamental
- Price
- POLA $1.73
- NCNA $0.05
- Analyst Decision
- POLA
- NCNA Buy
- Analyst Count
- POLA 0
- NCNA 2
- Target Price
- POLA N/A
- NCNA $25.00
- AVG Volume (30 Days)
- POLA 9.3K
- NCNA 161.7M
- Earning Date
- POLA 05-16-2025
- NCNA 06-02-2025
- Dividend Yield
- POLA N/A
- NCNA N/A
- EPS Growth
- POLA N/A
- NCNA N/A
- EPS
- POLA N/A
- NCNA N/A
- Revenue
- POLA $13,918,000.00
- NCNA N/A
- Revenue This Year
- POLA N/A
- NCNA N/A
- Revenue Next Year
- POLA N/A
- NCNA N/A
- P/E Ratio
- POLA N/A
- NCNA N/A
- Revenue Growth
- POLA 8.08
- NCNA N/A
- 52 Week Low
- POLA $1.68
- NCNA $0.03
- 52 Week High
- POLA $4.90
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- POLA 33.67
- NCNA 37.23
- Support Level
- POLA $1.77
- NCNA $0.04
- Resistance Level
- POLA $1.87
- NCNA $0.06
- Average True Range (ATR)
- POLA 0.06
- NCNA 0.01
- MACD
- POLA 0.01
- NCNA 0.03
- Stochastic Oscillator
- POLA 26.32
- NCNA 59.60
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.